Lab News
CVS Health paves way for genetic testing of cancer patients
December 12, 2019 -- CVS Health is launching a program that will facilitate genetic testing for cancer patients at the point of prescribing to guide personalized treatment for members of its Aetna subsidiary and other insurance companies.  Discuss
Agendia's MammaPrint refines risk scoring in younger cancer patients
December 12, 2019 -- Agendia's MammaPrint 70-gene panel can be used to refine risk in patients 50 years of age and younger with early breast cancer, which may be helpful in guiding some to less-intensive treatment regimens, according to a poster study presented by the company at the San Antonio Breast Cancer Symposium.  Discuss
Pathologists get to the bottom of AML subtypes
December 12, 2019 -- Whole genome and transcriptome sequencing enabled more precise assessment of acute myeloid leukemia (AML) and myelodysplastic syndromes, shedding light on their true genetic natures, in a new study presented at the American Society of Hematology annual meeting in Orlando, FL.  Discuss
Inflammatory marker sCD14 lurks in dementia
December 11, 2019 -- Higher circulating levels of the inflammatory biomarker plasma soluble CD14 (sCD14) were associated with brain atrophy and dementia in an analysis of data from two observational heart health studies. The association was reported on December 9 in the journal Neurology.  Discuss
Testing for BPA safety comes under the microscope
December 10, 2019 -- Accepted testing for bisphenol A (BPA) in urine underestimates the chemical's levels in humans, and a new method provides a more accurate and concerning picture, researchers claim in a report published in Lancet Diabetes & Endocrinology on December 5.  Discuss
Study finds room for improvement in youth HCV screening
December 10, 2019 -- There is room for improvement in screening and treatment for hepatitis C virus (HCV) infection in at-risk youths ages 13 to 21, according to a large study of U.S. federally qualified health centers published as a research letter in the Journal of the American Medical Association on December 10.  Discuss
Startup develops POC diagnostic for tuberculosis
December 9, 2019 -- Diascopic, a Cleveland-based diagnostic technology startup, is using a grant from the U.S. Small Business Innovation Research program to develop a near point-of-care (POC) diagnostic platform for detecting the bacterium that causes tuberculosis.  Discuss
U.K. vitamin D study feeds into global debates on appropriate use
December 5, 2019 -- Prescriptions for vitamin D to U.K. children have risen dramatically over the years, and medical records suggest inappropriate use, according to a study published online December 3 in BMJ Open. The results feed into international debates about overuse and the high costs of supplementation and testing.  Discuss
High cost rules out NIPT as 1st test for Down syndrome
December 4, 2019 -- Noninvasive prenatal testing (NIPT) is better than conventional testing for Down syndrome, but its high cost must come down to make it more viable as a first-tier screening test, according to a Canadian study published on December 4 in PLOS One.  Discuss
Prostate cancer urine test adapted for home sampling
December 3, 2019 -- The investigational prostate urine risk classifier is feasible for use with the collection of samples at home, according to a recent study by U.K. researchers.  Discuss
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets